A decade ago, the US Supreme Court decided Association for Molecular Pathology v. Myriad Genetics, Inc., concluding that isolated genes were not patentable subject matter …
D Nicol, RC Dreyfuss, ER Gold, W Li… - Annual review of …, 2019 - annualreviews.org
This review explores the recent divergence in international patent law relating to genes and associated subject matter. This divergence stems primarily from decisions of the highest …
Recently it has become possible to query the great diversity of natural antibody repertoires using next-generation sequencing (NGS). These methods are capable of producing millions …
How does emerging patent case law in the US and Europe affect precision medicine? | Nature Biotechnology Skip to main content Thank you for visiting nature.com. You are using a browser …
European patent protection for medical uses of known products and drug repurposing | Nature Biotechnology Skip to main content Thank you for visiting nature.com. You are using a browser …
Mapping the European patent landscape for medical uses of known products | Nature Biotechnology Skip to main content Thank you for visiting nature.com. You are using a browser …
All reasonable precautions have been taken by WHO, WIPO and WTO to verify the information contained in this publication. However, the published material is being …
Abstract Recent US Supreme Court decisions have invalidated patent claims on isolated genomic DNA, and testing methods that applied medical correlations using conventional …
The use and projected use of plant growth-promoting bacteria on a large scale requires the examination of a number of issues. A number of those issues are addressed in this chapter …